🔗 Share this article Chancellor Reeves Aims for Focused Measures on Household Expenses in Forthcoming Budget Chancellor Rachel Reeves has announced she is planning "focused measures to address cost of living issues" in the forthcoming Budget. During an interview with media outlets, she stated that curbing price rises is a collective duty of both the government and the Bank of England. The UK's price growth is forecast to be the highest among the G7 advanced economies this year and next. Possible Energy Bill Measures It is understood the administration could intervene to reduce energy bills, for example by reducing the current 5% rate of VAT applied on energy. A further possibility is to lower some of the regulatory levies presently added to household expenses. Budgetary Limitations and Expert Predictions The administration will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much space there is for such actions. The consensus from the majority of economists is that the Chancellor will have to announce tax rises or expenditure reductions in order to fulfill her voluntary borrowing rules. Previously on Thursday, estimates indicated there was a twenty-two billion pound shortfall for the Treasury chief to resolve, which is at the lower end of expectations. "It is a collective job between the central bank and the government to further reduce some of the causes of price increases," Reeves informed the BBC in the US capital, at the yearly gatherings of the IMF and World Bank. Tax Commitments and Global Issues While a great deal of the attention has been on expected tax rises, the Treasury chief said the most recent data from the fiscal watchdog had not changed her commitment to manifesto promises not to increase tax levels on earnings tax, VAT or National Insurance. She attributed an "unpredictable world" with increasing geopolitical and commercial issues for the fiscal tax moves, likely to be focused on those "with the broadest shoulders." International Economic Disputes Addressing apprehensions about the United Kingdom's economic relations with China she said: "Our national security invariably come first." Recent statement by Chinese authorities to strengthen export controls on rare earths and other resources that are essential for advanced tech production led American leader Donald Trump to propose an additional 100% tariff on goods from the Asian country, raising the prospect of an full-scale trade war between the two global powers. The American finance chief labeled the Chinese action "economic coercion" and "a global supply chain power grab." Asked about considering the US offer to participate in its battle with China, Reeves said she was "extremely troubled" by China's measures and called on the Chinese government "not to put up barriers and restrict access." She said the action was "bad for the international commerce and creates additional challenges." "It is my opinion there are sectors where we must address China, but there are also important chances to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that balance appropriate." The chancellor also stated she was cooperating with international partners "on our own critical minerals approach, so that we are less reliant." NHS Drug Costs and Funding The Chancellor also acknowledged that the cost the NHS spends on drugs could increase as a result of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and investment. A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or canceling investments in the United Kingdom, with several attributing the insufficient payments they are obtaining. Recently, the government science advisor said the cost the health service pays for medicines would need to go up to stop companies and drug research funding departing from the UK. Reeves told media: "We have seen as a result of the payment system, that clinical trials, new drugs have not been provided in the United Kingdom in the manner that they are in other EU nations." "We want to ensure that patients receiving care from the National Health Service are able to access the finest essential treatments in the world. And so we are reviewing these issues, and... looking to obtain additional funding into the UK."